Zurex Pharma, Inc. is a medical technology company with a novel antimicrobial technology platform. The company's mission is to develop and commercialize a portfolio of innovative antimicrobial products designed to prevent healthcare acquired infections with a focus on surgical site wounds and catheter-related infections.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 05/22/12 | $6,200,000 | Series A |
Baird Capital State of Wisconsin Investment Board | undisclosed |
